NASDAQ$SIBN

SI-BONE Inc · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

Reported financial results for the quarter ended September 30, 2022.

SI-BONE reported a record worldwide revenue of $26.4 million for Q3 2022, representing a 19% increase over the corresponding period in 2021. The company's U.S. revenue also hit a record of $24.6 million, a 21% increase year-over-year. The gross margin was 84% for the third quarter 2022.

  • Record worldwide revenue of $26.4 million for Q3 2022, a 19% increase year-over-year.
  • Record U.S. revenue of $24.6 million for Q3 2022, a 21% increase year-over-year.
  • Gross margin of 84% for Q3 2022.
  • Over 800 U.S. active surgeons in Q3, a 27% growth year-over-year.

Headline financials

Total Revenue

$26.4M

Previous: $22.3M+18.6%
EPS (adj)

-$0.41

Previous: -$0.48+14.6%
Gross margin

84.0%

Previous: 89.0%-5.6%
Capital Expenditures

-$7.85M

Previous: -$4.61M-70.1%
Free Cash Flow

-$22M

Previous: -$20.5M-7.4%
Net Income

-$14.2M

Previous: -$15.9M+10.8%
Operating Income

-$13.6M

Previous: -$13.2M-2.8%
Gross Profit

$22.3M

Previous: $19.8M+12.4%
Cash & Equivalents

$26.3M

Previous: $59.9M-56.1%
Total Assets

$158M

Previous: $194M-18.4%
Stock-Based Comp

$5.92M

Previous: $4.24M+39.6%

Revenue & EPS history

SI-BONE · Revenue · Quarterly

$26.4M

Q3 2022+18.6%vs Q3 2021
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Forward guidance

The Company expects 2022 worldwide revenue to be in the range of $104 million to $105 million, implying growth of approximately 16% to 17%.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

-1.8%

Avg return

Earnings day

-1.3%

Avg return

5 days after

+0.0%

Avg return

30 days after

40%

12 / 30 earnings

Positive

+16.2%

Q4 2022

Best reaction

-23.7%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.3%+15.3%+25.1%
Q4 2025-1.0%-0.6%-17.8%
Q3 2025+16.1%+11.1%+20.0%
Q1 2025+15.6%+29.8%+33.8%
Q4 2024+5.6%+3.7%-19.9%
Q3 2024-17.5%-18.8%-14.5%
Q2 2024-3.6%-5.2%+10.2%
Q1 2024+10.4%+8.0%-1.1%
Q4 2023-12.4%-15.7%-22.0%
Q3 2023-4.7%-12.4%-0.9%
Q2 2023-12.5%-9.6%-7.1%
Q1 2023+9.6%-0.3%+13.9%
Q4 2022+16.2%+19.5%+14.0%
Q3 2022-23.1%-16.4%-26.5%
Q2 2022-6.4%+0.1%+3.5%
Q1 2022-23.7%-27.6%-12.2%
Q4 2021+2.4%+3.2%+3.2%
Q3 2021-7.8%-10.9%-13.6%
Q2 2021-15.1%-18.9%-18.3%
Q1 2021-7.0%-7.5%-17.2%
Q4 2020+4.0%+6.6%+8.3%
Q3 2020+3.2%+0.5%+10.7%
Q2 2020+13.6%+17.7%+31.7%
Q1 2020+9.0%+11.9%+16.3%
Q4 2019-11.9%-21.7%-28.9%
Q3 2019-4.4%-4.5%-0.6%
Q2 2019+6.8%+10.7%+11.3%
Q1 2019-3.9%-8.1%-1.5%
Q4 2018-4.6%-3.6%-9.4%
Q3 2018-3.0%+4.8%+10.5%
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q1 2016
Q1 2015
Q4 2014
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro